Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

With 2024 coming to a close, time is running out for manufacturing companies to take advantage of many year-end tax benefits.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
Discover key insights from NAM's Q2 2024 survey on manufacturing industry challenges, workforce issues and the impact of potential tax increases.
Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.
The credit is aimed at bolstering and incentivizing the emerging biotechnology sector to create jobs and invest in NYC and is available 1/1/23-1/1/26.
The quarterly survey highlights a positive outlook for companies tempered by concerns about possible taxation and regulatory pressures.
Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.
In a business sale, due diligence is critical to mitigate the risk of unexpected tax issues for buyers and sellers. Find out key components of tax due diligence.
The NAM survey conducted in November 2023 covers key trends and economic outlook among manufacturers. Learn more.
A summary of changes to R&E expenditure tax treatment in the proposed Tax Relief for American Families and Workers Act of 2024.
Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.